Surgical Science Sweden AB (publ) (STO:SUS)
Sweden
· Delayed Price · Currency is SEK 159.40
-0.70 (-0.44%)
Feb 21, 2025, 5:29 PM CET
STO:SUS Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 131.65 | 233.97 | 187.97 | 86.25 | 15.61 | Upgrade
|
| Depreciation & Amortization | 60.52 | 38.4 | 35.66 | 23.9 | 10.25 | Upgrade
|
| Other Amortization | - | 17.21 | 15.93 | 9.62 | 6.73 | Upgrade
|
| Other Operating Activities | 10.95 | -45.64 | -44.46 | -34 | -3.52 | Upgrade
|
| Change in Accounts Receivable | -20.24 | 31.91 | -70.76 | -84.57 | 1.86 | Upgrade
|
| Change in Inventory | -11.56 | -19.57 | -21.72 | 6.46 | -5.27 | Upgrade
|
| Change in Other Net Operating Assets | -34.09 | -17.99 | 26.87 | 31.43 | -2.43 | Upgrade
|
| Operating Cash Flow | 137.23 | 238.29 | 129.49 | 39.08 | 23.23 | Upgrade
|
| Operating Cash Flow Growth | -42.41% | 84.03% | 231.31% | 68.28% | -57.93% | Upgrade
|
| Capital Expenditures | -6.1 | -10.46 | -9.35 | -3.87 | -0.4 | Upgrade
|
| Cash Acquisitions | - | - | - | -2,718 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -41.43 | -33.67 | -25.2 | -10.51 | -8.3 | Upgrade
|
| Investing Cash Flow | -47.53 | -44.13 | -34.55 | -2,733 | -8.69 | Upgrade
|
| Long-Term Debt Issued | 235.41 | - | 17.09 | - | - | Upgrade
|
| Long-Term Debt Repaid | -7.76 | -3.3 | - | -31.72 | -5.14 | Upgrade
|
| Total Debt Repaid | -7.76 | -3.3 | - | -31.72 | -5.14 | Upgrade
|
| Net Debt Issued (Repaid) | 227.65 | -3.3 | 17.09 | -31.72 | -5.14 | Upgrade
|
| Issuance of Common Stock | - | - | - | 3,039 | 7.86 | Upgrade
|
| Other Financing Activities | - | 19.15 | - | -84.87 | 1.49 | Upgrade
|
| Financing Cash Flow | 227.65 | 15.85 | 17.09 | 2,922 | 4.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | 16.44 | -9.38 | 5.02 | 0.59 | -0.8 | Upgrade
|
| Net Cash Flow | 333.79 | 200.63 | 117.05 | 229.52 | 17.94 | Upgrade
|
| Free Cash Flow | 131.12 | 227.84 | 120.14 | 35.21 | 22.83 | Upgrade
|
| Free Cash Flow Growth | -42.45% | 89.65% | 241.18% | 54.26% | -58.41% | Upgrade
|
| Free Cash Flow Margin | 14.83% | 25.81% | 14.97% | 9.60% | 21.78% | Upgrade
|
| Free Cash Flow Per Share | 2.57 | 4.47 | 2.36 | 0.83 | 0.66 | Upgrade
|
| Cash Income Tax Paid | 27.69 | 14.55 | 8.48 | 3.43 | 9.07 | Upgrade
|
| Levered Free Cash Flow | 44.54 | 95.48 | 95.86 | 17.79 | 10.32 | Upgrade
|
| Unlevered Free Cash Flow | 44.54 | 95.88 | 96.19 | 18.11 | 10.65 | Upgrade
|
| Change in Net Working Capital | 58.65 | 35.16 | 18.88 | 52.89 | 10.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.